(Q28568340)

1

1 reference

31 January 2017

Anna Vasilaki

2

1 reference

31 January 2017

Dominique Fehlmann

3

1 reference

31 January 2017

Andreas Kastellakis

4

1 reference

31 January 2017

Christina Spyraki

6

1 reference

31 January 2017

Kyriaki Thermos

Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.

7

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

31 January 2017

Neuropsychopharmacology

1 reference

31 January 2017

34

1 reference

31 January 2017

4

1 reference

31 January 2017

952–963

1 reference

31 January 2017

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

Effect of serotonergic agents on regional concentrations of somatostatin- and neuropeptide Y-like immunoreactivities in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

CSF Somatostatin in Affective Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

Pindolol augmentation of antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

A review of central 5-HT receptors and their function

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

New approaches to antidepressant drug discovery: beyond monoamines

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Effects of sertraline on regional neuropeptide concentrations in olfactory bulbectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Elevated concentrations of CRF in the locus coeruleus of depressed subjects

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

The Regional Distribution of Somatostatin in the Rat Brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Somatostatin content and receptors in the cerebral cortex of depressed and control subjects

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Effect of Intraventricular Injection of Dopamine, Norepinephrine, Acetylcholine, and 5-Hydroxytryptamine on Immunoreactive Somatostatin Release into Rat Hypophyseal Portal Blood*

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

125I-[Tyr0,D-Trp8]somatostatin-14 binding sites in the locus coeruleus of the rat are located on both ascending and descending projecting noradrenergic cells

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Effects of acute and chronic desipramine treatment on somatostatin receptors in brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Evidence that somatostatin sst2 receptors mediate striatal dopamine release

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Classification and nomenclature of somatostatin receptors

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Repeated administration of antidepressant drugs reduces regional somatostatin concentrations in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Rat somatostatin receptor subtype 4 can be made sensitive to agonist-induced internalization by mutation of a single threonine (residue 331).

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Desmethylimipramine pretreatment prevents 6-hydroxydopamine induced somatostatin receptor reduction in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Chemical identity of 5-HT2A receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Reduction of somatostatin receptors in rat hippocampus by treatment with 5,7-dihydroxytryptamine

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Differential internalization of somatostatin in COS-7 cells transfected with SST1 and SST2 receptor subtypes: a confocal microscopic study using novel fluorescent somatostatin derivatives

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Chronic antidepressant treatment modulates the release of somatostatin in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Chronic desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Somatostatin Release from Rat Hypothalamus in Vitro: Effects of Melatonin and Serotonin*

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Agonist-induced endocytosis of rat somatostatin receptor 1.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Cerebrospinal fluid somatostatin and psychiatric illness

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Molecular cloning and functional characterization of a rat somatostatin sst2(b) receptor splice variant

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Current perspectives on the development of non-biogenic amine-based antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Receptor-mediated internalization of somatostatin in rat cortical and hippocampal neurons

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina?

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Dopamine-somatostatin interactions in the rat striatum: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

The somatostatin receptor (sst1) modulates the release of somatostatin in the nucleus accumbens of the rat

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: A light and electron microscopic study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

From monoamines to genomic targets: a paradigm shift for drug discovery in depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.133

7 January 2021